HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Bart Meyns Ramadan Jashari Willem Daenen Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meyns, B. Articles by Daenen, W. Search for Related Content PubMed PubMed Citation Articles by Meyns, B. Articles by Daenen, W. Related Collections Congenital - acyanotic Valve disease

Eur J Cardiothorac Surg 2005;28:211-216
© 2005 Elsevier Science NL

Original articles

Factors influencing the survival of cryopreserved homografts. The second homograft performs as well as the first

Bart Meyns ^{a , *} , Ramadan Jashari ^b , Marc Gewillig ^c , Luc Mertens ^c , Arnot Komárek ^d , Emmanuel Lesaffre ^d , Werner Budts ^e , Willem Daenen ^a

^a Department of Cardiac Surgery, University Hospital Gasthuisberg, Herestraat 49, 3000 Leuven, Belgium
^b European Homograft Bank, Brussels, Belgium
^c Department of Pediatric Cardiology, University Hospital Gasthuisberg, Leuven, Belgium
^d Biostatistical Centre, Catholic University, Leuven, Belgium
^e Department of Cardiology, Catholic University, Leuven, Belgium

Received 23 September 2004; received in revised form 28 February 2005; accepted 30 March 2005.

^* Corresponding author. Tel.: +32 1 634 4260; fax: +32 1 643 4616. (Email: bart.meyns{at}uz.kuleuven.ac.be).

Abstract

Objective: To determine the life span of cryopreserved homografts implanted in the right ventricular outflow tract and the factors influencing it. Methods: From 1989 through 2003, we reconstructed the pulmonary valve with 301 homografts in 272 patients (median age 13 years; range 4 days–69 years). Indications were tetralogy of Fallot (136), truncus (23), Rastelli repair (11), double outlet ventricle (13), endocarditis (5), and the Ross operation (84). Median follow-up was 5.7 years (range 0–14). We analyzed possible predictors of graft replacement by simple and multiple Cox regression. Results: Actuarial survival was 96±1.2% at 1, 95±1.4% at 5, and 94±1.5% at 10 years follow-up. Three homografts were explanted because of endocarditis (excluded from the analysis). Freedom from explantation was 99.6±0.4% at 1, 94.5±1.7% at 5, and 81.8±4.1% at 10 years. Variables, significantly related to explantation in the univariate analysis, were younger age, small graft size, implantation in a non-anatomical position, the aortic donor homograft, a shorter aortic cross-clamp time and the implantation of a second homograft. In the multiple model, non-anatomical position (P=0.001), smaller graft size (P<0.0001) or younger age (on square root scale, P<0.0001) and clamp time (P=0.01) remain as independent risk factors. Immunological variables, like blood group incompatibility, implantation of a second homograft and short warm ischemic time were not significant. Conclusions: The life span of a cryopreserved homograft is determined by graft size (correlates with age) and the non-anatomic position (correlates with indication). In a specific patient, the second homograft performs as well as the first.

Key Words: Congenital heart surgery • Biological heart valve • Allograft

This article has been cited by other articles:

				E. Troost, B. Meyns, W. Daenen, F. Van de Werf, M. Gewillig, K. Van Deyk, P. Moons, and W. Budts Homograft survival after tetralogy of Fallot repair: determinants of accelerated homograft degeneration Eur. Heart J., October 2, 2007; 28(20): 2503 - 2509. [Abstract] [Full Text] [PDF]

				T. Oosterhof, A. van Straten, H. W. Vliegen, F. J. Meijboom, A. P.J. van Dijk, A. M. Spijkerboer, B. J. Bouma, A. H. Zwinderman, M. G. Hazekamp, A. de Roos, et al. Preoperative Thresholds for Pulmonary Valve Replacement in Patients With Corrected Tetralogy of Fallot Using Cardiovascular Magnetic Resonance Circulation, July 31, 2007; 116(5): 545 - 551. [Abstract] [Full Text] [PDF]

				D. Boethig, H. Goerler, M. Westhoff-Bleck, M. Ono, A. Daiber, A. Haverich, and T. Breymann Evaluation of 188 consecutive homografts implanted in pulmonary position after 20 years Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 133 - 142. [Abstract] [Full Text] [PDF]

				T. Oosterhof, F. J. Meijboom, H. W. Vliegen, M. G. Hazekamp, A. H. Zwinderman, B. J. Bouma, A. P.J. van Dijk, and B. J.M. Mulder Long-term follow-up of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot Eur. Heart J., June 2, 2006; 27(12): 1478 - 1484. [Abstract] [Full Text] [PDF]